Vollenweider FX - Search Results

1

Ketamine induces multiple individually distinct whole-brain functional connectivity signatures.

Moujaes F, Ji JL, Rahmati M, Burt JB, Schleifer C, Adkinson BD, Savic A, Santamauro N, Tamayo Z, Diehl C, Kolobaric A, Flynn M, Rieser N, Fonteneau C, Camarro T, Xu J, Cho Y, Repovs G, Fineberg SK, Morgan PT, Seifritz E, Vollenweider FX, Krystal JH, Murray JD, Preller KH, Anticevic A. Moujaes F, et al. Among authors: vollenweider fx. Elife. 2024 Apr 17;13:e84173. doi: 10.7554/eLife.84173. Elife. 2024. PMID: 38629811 Free PMC article. Clinical Trial.

2

Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.

Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E, Vollenweider FX. Schmidt A, et al. Among authors: vollenweider fx. Neuropsychopharmacology. 2012 Mar;37(4):865-75. doi: 10.1038/npp.2011.261. Epub 2011 Oct 26. Neuropsychopharmacology. 2012. PMID: 22030715 Free PMC article. Clinical Trial.

3

Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.

Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. Kometer M, et al. Among authors: vollenweider fx. Biol Psychiatry. 2012 Dec 1;72(11):898-906. doi: 10.1016/j.biopsych.2012.04.005. Epub 2012 May 10. Biol Psychiatry. 2012. PMID: 22578254 Clinical Trial.

4

The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions.

Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F. Schmidt A, et al. Psychopharmacology (Berl). 2013 Jan;225(1):227-39. doi: 10.1007/s00213-012-2811-0. Epub 2012 Jul 27. Psychopharmacology (Berl). 2013. PMID: 22836372 Free article.

5

Increased sensorimotor gating in recreational and dependent cocaine users is modulated by craving and attention-deficit/hyperactivity disorder symptoms.

Preller KH, Ingold N, Hulka LM, Vonmoos M, Jenni D, Baumgartner MR, Vollenweider FX, Quednow BB. Preller KH, et al. Among authors: vollenweider fx. Biol Psychiatry. 2013 Feb 1;73(3):225-34. doi: 10.1016/j.biopsych.2012.08.003. Epub 2012 Sep 5. Biol Psychiatry. 2013. PMID: 22959126 Free article.

6

Crowding deficits in the visual periphery of schizophrenia patients.

Kraehenmann R, Vollenweider FX, Seifritz E, Kometer M. Kraehenmann R, et al. Among authors: vollenweider fx. PLoS One. 2012;7(9):e45884. doi: 10.1371/journal.pone.0045884. Epub 2012 Sep 26. PLoS One. 2012. PMID: 23049884 Free PMC article.

7

Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.

Bernasconi F, Schmidt A, Pokorny T, Kometer M, Seifritz E, Vollenweider FX. Bernasconi F, et al. Among authors: vollenweider fx. Cereb Cortex. 2014 Dec;24(12):3221-31. doi: 10.1093/cercor/bht178. Epub 2013 Jul 16. Cereb Cortex. 2014. PMID: 23861318 Free article. Clinical Trial.

8

Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometry.

Csomor PA, Preller KH, Geyer MA, Studerus E, Huber T, Vollenweider FX. Csomor PA, et al. Among authors: vollenweider fx. Neuropsychopharmacology. 2014 Sep;39(10):2485-96. doi: 10.1038/npp.2014.102. Epub 2014 May 7. Neuropsychopharmacology. 2014. PMID: 24801767 Free PMC article.

9

Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.

Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E, Vollenweider FX. Kraehenmann R, et al. Among authors: vollenweider fx. Biol Psychiatry. 2015 Oct 15;78(8):572-81. doi: 10.1016/j.biopsych.2014.04.010. Epub 2014 Apr 26. Biol Psychiatry. 2015. PMID: 24882567 Clinical Trial.

10

The role of GABAB receptors in human reinforcement learning.

Ort A, Kometer M, Rohde J, Seifritz E, Vollenweider FX. Ort A, et al. Among authors: vollenweider fx. Eur Neuropsychopharmacol. 2014 Oct;24(10):1606-14. doi: 10.1016/j.euroneuro.2014.08.013. Epub 2014 Aug 26. Eur Neuropsychopharmacol. 2014. PMID: 25194227 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters